Acusensus Limited (ASX:ACE)

Acusensus Statistics

Total Valuation

Acusensus has a market cap or net worth of AUD 264.13 million. The enterprise value is 262.26 million.

Market Cap	264.13M
Enterprise Value	262.26M

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Acusensus has 140.87 million shares outstanding. The number of shares has increased by 5.90% in one year.

Current Share Class	140.87M
Shares Outstanding	140.87M
Shares Change (YoY)	+5.90%
Shares Change (QoQ)	+0.76%
Owned by Insiders (%)	15.94%
Owned by Institutions (%)	20.95%
Float	84.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.45
PB Ratio	5.64
P/TBV Ratio	5.65
P/FCF Ratio	n/a
P/OCF Ratio	31.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 147.50, with an EV/FCF ratio of -52.54.

EV / Earnings	-99.95
EV / Sales	4.42
EV / EBITDA	147.50
EV / EBIT	n/a
EV / FCF	-52.54

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.17.

Current Ratio	2.49
Quick Ratio	1.61
Debt / Equity	0.17
Debt / EBITDA	4.46
Debt / FCF	-1.59
Interest Coverage	-27.87

Financial Efficiency

Return on equity (ROE) is -6.34% and return on invested capital (ROIC) is -5.25%.

Return on Equity (ROE)	-6.34%
Return on Assets (ROA)	-3.99%
Return on Invested Capital (ROIC)	-5.25%
Return on Capital Employed (ROCE)	-6.69%
Revenue Per Employee	227,395
Profits Per Employee	-10,054
Employee Count	261
Asset Turnover	0.97
Inventory Turnover	22.13

Taxes

Income Tax	-703,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +110.67% in the last 52 weeks. The beta is -0.22, so Acusensus's price volatility has been lower than the market average.

Beta (5Y)	-0.22
52-Week Price Change	+110.67%
50-Day Moving Average	1.41
200-Day Moving Average	1.12
Relative Strength Index (RSI)	61.76
Average Volume (20 Days)	423,207

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Acusensus had revenue of AUD 59.35 million and -2.62 million in losses. Loss per share was -0.02.

Revenue	59.35M
Gross Profit	26.57M
Operating Income	-3.90M
Pretax Income	-3.33M
Net Income	-2.62M
EBITDA	-366,000
EBIT	-3.90M
Loss Per Share	-0.02

Balance Sheet

The company has 9.80 million in cash and 7.93 million in debt, giving a net cash position of 1.87 million or 0.01 per share.

Cash & Cash Equivalents	9.80M
Total Debt	7.93M
Net Cash	1.87M
Net Cash Per Share	0.01
Equity (Book Value)	46.79M
Book Value Per Share	0.33
Working Capital	22.68M

Cash Flow

In the last 12 months, operating cash flow was 8.27 million and capital expenditures -13.26 million, giving a free cash flow of -4.99 million.

Operating Cash Flow	8.27M
Capital Expenditures	-13.26M
Free Cash Flow	-4.99M
FCF Per Share	-0.04

Margins

Gross margin is 44.76%, with operating and profit margins of -6.57% and -4.42%.

Gross Margin	44.76%
Operating Margin	-6.57%
Pretax Margin	-5.61%
Profit Margin	-4.42%
EBITDA Margin	-0.62%
EBIT Margin	-6.57%
FCF Margin	n/a

Dividends & Yields

Acusensus does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.90%
Shareholder Yield	-5.90%
Earnings Yield	-0.99%
FCF Yield	-1.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 5.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	5

Scores

Acusensus has an Altman Z-Score of 3.66 and a Piotroski F-Score of 3.

Altman Z-Score	3.66
Piotroski F-Score	3